A 2012 study of patients with low-tumor-burden follicular lymphoma showed that the 4-year freedom from treatment failure rate ...

Follicular lymphoma is an indolent malignancy with a generally favorable prognosis, with survival often measured in decades.

Discover key insights from ADC Therapeutics' Q4 2024 earnings call, including ZYNLONTA’s commercial success, clinical trial updates, and strategic ...

Computed tomography (CT) and 18 F-fluorodeoxyglucose (FDG)-PET are the established imaging modalities for staging and response assessment in malignant lymphoma. Combined FDG-PET/CT has higher ...

What Is B-Cell Lymphoma? B-cell lymphoma is a cancer that forms in your white blood cells called lymphocytes. These cells are made by your lymphatic system, which plays an important role in immunity.

Subgroup analysis was performed for diffuse large B-cell lymphoma (DLBCL) and indolent lymphomas, which included marginal zone lymphoma (MZL), Grade 1-2 follicular lymphoma (FL), and low-grade B-cell ...

Routine screening tests may reveal findings that lead to an incidental diagnosis of SM. A middle-aged woman was diagnosed with indolent systemic mastocytosis (SM) following investigations after an ...

The decision is based on results from the global, phase 2 TRANSCEND FL study, the largest clinical trial to date to evaluate a CAR T cell therapy in patients with relapsed or refractory indolent ...

People may have a bone marrow transplant during or after cancer treatment or if lymphoma relapses or is in remission. Bone marrow transplants allow doctors to use high dose chemotherapy and ...

About 30 percent of all non-Hodgkin lymphoma diagnoses in the United States are DLBCL. Although it is an aggressive cancer that can spread quickly, it is treatable. These can be symptoms of many ...